The factors associated with a functional outcome after ischemic stroke in diabetic patients: The Fukuoka Stroke Registry

详细信息    查看全文

• 作者：Takahiro Kuwashiro¹ ; Masahiro Kamouchi ; ¹ ; ^{kamouchi@intmed2.med.kyushu-u.ac.jp} ; Tetsuro Ago¹ ; Jun Hata¹ ; Hiroshi Sugimori¹ ; Takanari Kitazono¹
• 关键词：Ischemic stroke ; Diabetes mellitus ; Outcome ; Proteinuria ; Angiotensin receptor blocker
• 刊名：Journal of the Neurological Sciences
• 出版年：2012
• 出版时间：15 February 2012
• 年：2012
• 卷：313
• 期：1-2
• 页码：110-114
• 全文大小：167 K

文摘

Background

The prognosis in ischemic stroke is poor in diabetic patients. However, scant research has so far been done on the predisposing factors associated with poor outcomes.

Methods

We prospectively investigated the background characteristics and prognosis at 3 months in 241 consecutive diabetic patients having their first ischemic stroke (153 males, 88 females, mean age ¡À SD, 71 ¡À 10 years). Poor functional outcome was defined as modified Rankin scale ?#xA0;3 at 3 months after onset.

Results

Univariate analysis showed that age, dementia, initial National Institutes of Health Stroke Scale (NIHSS) score, systolic blood pressure on admission, proteinuria, stroke subtype, and prior use of angiotensin receptor blocker (ARB) were significantly related to an outcome at 3 months after onset. A multivariate logistic regression analysis showed that age (odds ratio (OR) 1.07, 95 % confidence interval (CI) 1.01 to 1.13, p = 0.017, per 1-year increase), NIHSS score (OR 1.22, 95 % CI 1.12 to 1.35, p < 0.001, per 1-score increase), and proteinuria (OR 4.22, 95 % CI 1.71 to 10.92, p = 0.002) were significantly and independently associated with poor clinical outcome after ischemic stroke in diabetic patients. Conversely, prior use of ARB (OR 0.28, 95 % CI 0.09 to 0.79, p = 0.023) was associated with a better outcome.

Conclusions

In diabetic patients, proteinuria was independently associated with a poor clinical outcome after ischemic stroke, whereas the prior use of ARB appeared to be beneficial.